<?xml version="1.0" encoding="UTF-8"?>
<p id="Par30">Blood-to-blood HCV transmission also occurs through haemodialysis and is more evident in developing populations. According to recent data, the range is between 8.5 and 62.7% [
 <xref ref-type="bibr" rid="CR27">27</xref>]. However, the results of the dialysis outcomes and practice patterns study, conducted in 308 dialysis centres in the industrialised world (France, Germany, Italy, Spain, the UK, Japan, and the USA) for a total of 8615 patients on haemodialysis, showed a prevalence of anti-HCV positive patients that ranged between 3 and 23% [
 <xref ref-type="bibr" rid="CR28">28</xref>].
</p>
